Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.
von Mässenhausen A, Sanders C, Brägelmann J, Konantz M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Lengerke C, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Int J Cancer. 2016 Nov 15;139(10):2359-69. doi: 10.1002/ijc.30279. Epub 2016 Jul 30. Int J Cancer. 2016. PMID: 27434411
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.
Göke F, Bode M, Franzen A, Kirsten R, Goltz D, Göke A, Sharma R, Boehm D, Vogel W, Wagner P, Lengerke C, Kristiansen G, Kirfel J, Van Bremen T, Bootz F, Heasley LE, Schröck A, Perner S. Göke F, et al. Among authors: schrock a. Mod Pathol. 2013 Oct;26(10):1298-306. doi: 10.1038/modpathol.2013.58. Epub 2013 Apr 26. Mod Pathol. 2013. PMID: 23619603 Free article.
Clinical and molecular implications of MED15 in head and neck squamous cell carcinoma.
Adler D, Offermann A, Halbach R, Vogel W, Braun M, Kristiansen G, Bootz F, Wenzel J, Mikut R, Lengerke C, Reischl M, Schröck A, Perner S. Adler D, et al. Among authors: schrock a. Am J Pathol. 2015 Apr;185(4):1114-22. doi: 10.1016/j.ajpath.2014.12.010. Epub 2015 Mar 16. Am J Pathol. 2015. PMID: 25791637 Free article.
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
von Mässenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Göke F, Franzen A, Heasley L, Kirfel J, Brägelmann J, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Target Oncol. 2016 Oct;11(5):631-642. doi: 10.1007/s11523-016-0431-z. Target Oncol. 2016. PMID: 27053219
MERTK as a novel therapeutic target in head and neck cancer.
von Mässenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Heasley L, Brägelmann J, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724. Oncotarget. 2016. PMID: 27081701 Free PMC article.
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.
von Mässenhausen A, Brägelmann J, Billig H, Thewes B, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Brossart P, Kirfel J, Perner S. von Mässenhausen A, et al. Among authors: schrock a. Int J Mol Sci. 2016 Dec 22;18(1):7. doi: 10.3390/ijms18010007. Int J Mol Sci. 2016. PMID: 28025482 Free PMC article.
258 results